# Zepbound Without Insurance: What It Actually Costs in 2026 **By TelosRX Editorial Team** · 2026-09-02 **If you are paying for Zepbound yourself, there is no single price. Eli Lilly publishes a self-pay ladder that starts at $299 per month and climbs with your dose, and one refill rule that can push a maintenance month from $449 to $699 if you miss it by a few days. This guide walks through what Zepbound actually costs without insurance as of publication, how the self-pay route works, and what changes when your dose goes up. It also covers what to do if a plan denies it, and where a compounded option from a service like [telos rx](https://www.telosrx.com) does and does not fit.** The short answer The cheapest published route to brand-name Zepbound with no insurance is Eli Lilly's own self-pay pricing, which it directs cash-paying patients to through LillyDirect Pharmacy. As of publication, Lilly's published self-pay terms are **$299 per month** at the 2.5 mg starting dose, **$399** at 5 mg and **$449** at 7.5 mg and above, with a refill condition attached to the higher doses. A "month" is 28 days, not a calendar month. Compounded tirzepatide through a telehealth service is a separate, different option that some people consider. It is not Zepbound, and it is not FDA-approved. [See compounded tirzepatide pricing →](https://www.telosrx.com/pages/tirzepatide) ## How much is Zepbound without insurance? Zepbound is Eli Lilly's tirzepatide product approved for weight management in adults with obesity, or with overweight plus a weight-related medical problem, and also for moderate-to-severe obstructive sleep apnea in adults with obesity. Lilly publishes different prices for different situations, and the situation you are in matters more than the drug does. Here is the full picture from Lilly's own coverage and savings page. Your situation Published Zepbound price Notes Self-pay, 2.5 mg starting dose $299 per month 2.5 mg is a starting dose and is not an approved maintenance dose. Self-pay, 5 mg $399 per month No refill-timing condition published at this dose. Self-pay, 7.5 mg through 15 mg $449 per month Conditional on refilling within 45 days. See the next section. Self-pay, if the refill condition is missed $499 to $699 per month Lilly's stated regular price: $499 at 7.5 mg, $699 at 10, 12.5 and 15 mg. Commercial insurance that covers it As little as $25 For up to a 3-month single-dose pen fill. Capped savings, see below. Commercial insurance that excludes the single-dose pen As low as $499 per month 28 days and up to 4 single-dose pens, via the savings card. Medicare, if eligible No more than $50 per month Medicare GLP-1 Bridge. Lilly states this is not a guarantee of coverage. Every figure above is taken from Eli Lilly's own [Zepbound coverage and savings page](https://zepbound.lilly.com/coverage-savings), including its published card terms and conditions, checked on September 1, 2026. One note on sourcing: Lilly's dose-by-dose ladder is written for the Zepbound KwikPen, and its self-pay card also covers a month supplied as four single-dose vials. LillyDirect's own storefront blocks automated access, so we have not independently confirmed vial pricing at every dose, and we are deliberately not quoting a Zepbound list price we could not verify on a Lilly page. Third-party sites disagree on both. Price your actual dose and format on LillyDirect before you plan around any number, including ours. Lilly states these cards expire on December 31, 2026 and that it can amend or revoke them at any time. ## Why your first month is your cheapest month This is the part most Zepbound cost articles skip, and it is the part that wrecks budgets. Zepbound is titrated. You start at 2.5 mg, and your prescriber typically steps you up over time toward a maintenance dose. Lilly's self-pay pricing follows that ladder upward, so the price you see advertised is the price of the dose almost nobody stays on. Lilly's own footnote says it plainly: 2.5 mg is a starting dose and is not an approved maintenance dose. Practically, that means the honest way to budget for Zepbound without insurance is not to look at $299. It is to look at $449, the published self-pay price at maintenance doses, and to treat the first month or two as an introductory rate. If $449 a month works for you, the entry price is a pleasant bonus. If only $299 works, you have a problem in about eight weeks, and it is better to know that now than to find out at the pharmacy. ## The 45-day refill rule that can add $250 to a month Lilly attaches a condition to the higher doses that is easy to miss and expensive to trip over. According to Lilly's published purchase offer terms, you automatically receive the $449 offer on your first purchase of 7.5 mg, 10 mg, 12.5 mg or 15 mg. To stay eligible, you must complete your next refill purchase within 45 days of the delivery or receipt date of your previous fill. Refill later than that, and the offer does not apply. Lilly's stated regular price then applies instead: $499 for 7.5 mg, and $699 for 10 mg, 12.5 mg and 15 mg. So a delayed refill at 10 mg is not a small penalty. On Lilly's published figures it is the difference between $449 and $699 for that month. The gap is larger than most people's grocery budget, and it can be triggered by something as ordinary as a delayed prescriber signature, a holiday, or a week of travel. **Key takeaway:** If you are self-paying at 7.5 mg or above, put the 45-day refill deadline in your calendar the day your box arrives. Count from the delivery date, not from the day you started using it. Lilly also caps the self-pay card at up to 11 prescription fills per calendar year. ## Pen, KwikPen or vial: the format decides which price you get Zepbound is not sold as one thing, and this is where the conflicting numbers online come from. Lilly's programs treat the formats differently. - **The single-dose pen.** The original format, four pens to a month. This is the one attached to the $25 savings-card price when a commercial plan covers it, and to the $499 self-pay-through-the-card price when a commercial plan does not. Lilly states explicitly that the $299 per month figure is for the KwikPen or vial, not the single-dose pen. - **The single-patient-use KwikPen.** One pen per 28-day month. This is the format Lilly's dose-by-dose self-pay ladder is written for, and where the $299, $399 and $449 numbers live. - **Single-dose vials.** Lilly's self-pay card describes a month as one KwikPen or four vials at the same starting price. Vials need syringes, which is a real difference in the experience even when the price matches. The takeaway is that a price you saw quoted online may simply be for a different format than the one your prescription is written for. Before you compare anything, know which of the three you are being prescribed, because it changes both the price and which program you are eligible for. ## How to get Zepbound without insurance, step by step None of this is complicated, but the order matters. 1. **Get a prescription.** Every route requires a valid prescription from a licensed prescriber for an approved use. No savings program substitutes for that. 2. **Decide which indication you are being treated for.** Zepbound is approved both for weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity. If you have symptoms of sleep apnea and have never been assessed, it is worth raising with your prescriber. Some plans apply different criteria to each indication, so which one you are being treated for can matter. 3. **Check Lilly's current prices yourself** on the coverage page linked above, then price your specific dose and format on LillyDirect. Do this before you call any pharmacy, so you know what a fair number looks like. 4. **Confirm which card you actually qualify for.** This trips people up constantly, and the next section explains it. 5. **Budget for the maintenance dose, not the starting dose,** and diarize the 45-day refill deadline if you are at 7.5 mg or above. ## The card trap: "no insurance" and "insurance that will not cover it" are different programs Lilly runs more than one Zepbound card, and they have opposite eligibility rules. Reading the wrong set of terms is the single most common reason people think they qualify for a price they do not. - **The Zepbound KwikPen Self-Pay Savings Card** is, in Lilly's words, for self-paying cash patients, and operates outside any health insurance program. Using it, you agree not to seek reimbursement from any third-party payer or apply the cost toward a deductible. This is the program behind the $299, $399 and $449 figures. - **The Zepbound Single-Dose Pen and Single-Patient-Use KwikPen Savings Card** requires you to be enrolled in a commercial drug insurance plan, and for the KwikPen specifically, one that does not cover it. Its terms exclude anyone enrolled in a state, federal or government-funded healthcare program, naming Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA and TRICARE. So if you have no insurance at all, the commercially insured card is not for you, and the self-pay card is. If you have a commercial plan that excludes weight-management drugs, you are in the second bucket, not the first. And if you are on Medicare, both cards exclude you. That is why Lilly publishes a separate route, the Medicare GLP-1 Bridge, at no more than $50 per month for eligible Part D patients. Eligibility criteria there are set through Medicare rather than by Lilly, and Lilly states this is not a guarantee of coverage. ## What to do if you have insurance but it will not cover Zepbound A large share of people searching for Zepbound with no insurance do have insurance. What they do not have is coverage for this specific drug. Weight-management medications are one of the most commonly carved-out categories in employer pharmacy benefits, and whether yours is covered reflects choices your employer or plan sponsor made, not your diagnosis alone. We cannot tell you what your plan will do, and no article can. Formularies at the large pharmacy benefit managers and insurers, including names like CVS Caremark, Express Scripts, OptumRx, UnitedHealthcare, Aetna and the Blue Cross Blue Shield plans, are revised on their own schedules and differ between employer groups using the same administrator. The only authoritative answer is in your plan documents and your member portal. What we can do is describe the machinery you are likely to meet. - **Prior authorization.** Many plans that do cover a GLP-1 require your prescriber to submit clinical justification before a pharmacy can fill it. Missing paperwork, rather than a clinical judgment, is a common reason a first attempt fails. - **Formulary exclusion.** Some plans exclude weight-management drugs as a category. Where that is the case, prior authorization typically does not help, because there is no covered benefit to authorize. - **Indication-specific criteria.** Because Zepbound carries an obstructive sleep apnea indication as well as a weight-management one, some plans apply different criteria to each. Ask your plan for the written criteria for both rather than assuming a single answer covers you. - **Step therapy.** Some plans require you to try a lower-cost option first, and to document that it did not work, before they will consider the drug you were prescribed. - **Quantity limits and renewal criteria.** Even approved coverage often carries limits on fills and periodic re-authorization tied to documented progress. - **Appeals.** A denial is generally not the end of it. Most plans have an internal appeal process, and where that fails, an external review by an independent reviewer is typically available. Both carry filing deadlines, so the date on the denial notice matters. Healthcare.gov publishes a plain-language [overview of how appealing an insurance decision works](https://www.healthcare.gov/appeal-insurance-company-decision/appeals/). Two things genuinely help. Ask your prescriber's office whether they have handled prior authorizations for this drug class before, because experienced offices know what documentation a given plan wants. And ask your plan directly for its written coverage criteria, since you are entitled to know what the bar is before you try to clear it. None of that guarantees an outcome. ## Cheapest way to get Zepbound: the honest option list If the real question is the cheapest way to get treated rather than Zepbound specifically, here is the whole set, including the options that do not point back to us. Option Worth knowing **Lilly's self-pay pricing** The cheapest published route to the FDA-approved brand itself. You get the actual approved product. Watch the dose ladder and the refill deadline. **The commercial savings card** Better than self-pay if you hold a commercial plan, whether or not it covers Zepbound. Government plans are excluded. **Appealing a denial** Free to attempt, and often the highest-value move, because covered access beats every cash price. Costs you time and paperwork. **Novo Nordisk's own direct channel** A different molecule with its own self-pay pricing. We cover it in our [Wegovy without insurance guide](https://www.telosrx.com/blogs/glp1/wegovy-without-insurance-cost). **Compounded tirzepatide via telehealth** Typically the lowest monthly cost, but a different, non-FDA-approved preparation. Details below. **Other prescription options** Older, lower-cost weight-management medicines exist and are sometimes covered when a GLP-1 is not. Ask your prescriber. See the [NIH NIDDK overview](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity). ## Where compounded tirzepatide fits, and where it does not This is where we have a commercial interest, so we will be precise about it. **telos rx does not sell Zepbound.** We are not affiliated with Eli Lilly, we cannot get you a discount on their product, and nothing on this page is an offer to supply a brand-name medication. What [telos rx](https://www.telosrx.com/pages/tirzepatide) offers is compounded tirzepatide, prepared by a licensed US compounding pharmacy and prescribed at a clinician's discretion after an online medical review. Compounded tirzepatide is **not a generic version of Zepbound, and there is no generic Zepbound**. It is a different preparation using the same active ingredient, tirzepatide, which acts on GLP-1 and GIP receptors involved in appetite and blood sugar regulation. **Compounded medications are not FDA-approved. They have not been reviewed by the FDA for safety, effectiveness or quality**, which is a real difference from the branded product and one worth weighing honestly rather than treating as a technicality. The FDA explains what that means in its [questions and answers on human drug compounding](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers). With that said plainly, here is what it costs. These are the published telos rx plan prices as of publication, verifiable on the product pages. - **Compounded semaglutide, $99 per month** (regularly $299) - **[Microdosed tirzepatide, $116 per month](https://www.telosrx.com/pages/microdosed-tirzepatide)**, a lower-dose route some people use to keep the monthly cost down - **Compounded tirzepatide, $139 per month** (regularly $399) - **Oral GLP-1, $269 per month** for people who would rather not inject The price does not climb as your dose is titrated, which is the practical difference from a dose-tiered ladder. Free two-day shipping is included in the plan price, as are quarterly labs. You can cancel in one click with no fee. If a provider declines you, you get a full refund, and charges are final once a prescription has reached the pharmacy. No insurance is accepted or billed, which is the point for people whose plans have already said no. Medications are dispensed by VialsRX and Jungle Jim's, and prescribing providers are with Arora Health Group. You can compare the options on the [telos rx GLP-1 options page](https://www.telosrx.com/pages/glp-1-options), or [start an online visit](https://start.telosrx.com/start-online-visit/weightloss) to have a provider review whether any of it is appropriate for you. Whether that trade is right for you depends on how you weigh cost against FDA approval, and that is genuinely a personal call. If FDA approval is your priority, Lilly's self-pay route described above is the better answer, and we would rather you take it than feel misled by us. Choose the brand Best if FDA approval matters most to you, if your prescriber specifically wants you on Zepbound, or if coverage may come later. Use Lilly's self-pay channel and price your own dose. Fight the denial Best if you hold commercial insurance and a documented clinical need. Covered access beats any cash price. Ask for the written criteria and use the appeal window. What we offer Compounded, cash-pay Best if the manufacturer prices are still out of reach and you accept that a compounded preparation is not FDA-approved. Flat monthly pricing, no insurance involved. [See if you qualify →](https://start.telosrx.com/start-online-visit/weightloss) For deeper cost breakdowns, read our guide to [how much tirzepatide costs without insurance](https://www.telosrx.com/blogs/glp1/how-much-is-tirzepatide-without-insurance), which covers the molecule rather than the brand, our [tirzepatide cost and price guide](https://www.telosrx.com/blogs/glp1/tirzepatide-cost-price-guide), and our explainer on [what compounded medications actually are](https://www.telosrx.com/blogs/glp1/what-is-compounded-semaglutide). ## Frequently asked questions ### How much is Zepbound without insurance in 2026? As of publication, Eli Lilly's published self-pay terms are $299 per month at the 2.5 mg starting dose, $399 at 5 mg, and $449 at 7.5 mg through 15 mg, with the higher doses conditional on refilling within 45 days of your previous delivery. Miss that window and Lilly's stated regular price applies: $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. A month is defined as 28 days. Verify current figures on Lilly's own page and price your specific dose on LillyDirect before budgeting, because Lilly can amend or revoke these programs at any time. ### What is the cheapest way to get Zepbound without insurance? The cheapest published route to the brand itself is Lilly's own self-pay pricing, which it directs cash-paying patients to through LillyDirect Pharmacy. Paying an ordinary pharmacy cash price with no program applied is the most expensive way to do it. Two details decide what you actually pay: your dose, because the self-pay price ladder climbs with it, and your refill timing at 7.5 mg and above. ### Why does the Zepbound price without insurance differ everywhere I look? Because Zepbound is sold in three formats with different program rules. The dose-by-dose self-pay ladder is written for the KwikPen, the self-pay card also covers a month supplied as four vials, and the single-dose pen sits under a separate savings card with different prices. On top of that, prices are dose-dependent, promotional terms carry expiry dates, and a quoted price without a date on it is already going stale. Always check which format and dose a number refers to. ### Can I use the Zepbound savings card if I have no insurance at all? Not the commercial one. Lilly's Single-Dose Pen and Single-Patient-Use KwikPen Savings Card requires enrollment in a commercial drug insurance plan and excludes anyone in a government-funded program such as Medicare, Medicaid, TRICARE or VA benefits. If you have no insurance, the program written for you is the Zepbound KwikPen Self-Pay Savings Card, which Lilly describes as being for self-paying cash patients and operating outside any insurance. Read the current terms for whichever applies to you, since eligibility rules change. ### Is compounded tirzepatide the same as Zepbound? No. There is no generic Zepbound, and compounded tirzepatide is not a generic, equivalent or substitute for it. It is a different preparation made by a compounding pharmacy using the same active ingredient, prescribed at a clinician's discretion. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. Zepbound and Mounjaro are trademarks of Eli Lilly and Company, and telos rx has no affiliation with Eli Lilly and does not sell its products. ### What is the cheapest tirzepatide with no insurance? It depends on what you are willing to trade. For the FDA-approved branded product, Lilly's self-pay channel is the cheapest published route. Compounded tirzepatide through a telehealth service is typically lower, with telos rx pricing at $139 per month for compounded tirzepatide and $116 per month for the microdosed option as of publication, held flat as your dose is titrated, but it is a non-FDA-approved preparation and that difference is real. Any prescription requires approval by a licensed provider, and approval is not guaranteed. _Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Wegovy and Ozempic are registered trademarks of Novo Nordisk. TelosRX is not affiliated with, endorsed by or sponsored by either company and does not sell, supply or dispense their products. All manufacturer prices cited were taken from Eli Lilly's own published pages on September 1, 2026 and are subject to change without notice. TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality; they are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. This article is general information, not medical, legal or insurance advice, and it does not predict what any plan will cover. Check your own plan documents and the manufacturer's current terms. TelosRX operates as an online-first, asynchronous telehealth service._ Compare plans and pricing at [telos rx](https://www.telosrx.com). **Tags:** compounded GLP-1, GLP-1, GLP-1 cost, insurance, tirzepatide, weight loss, Zepbound cost --- > Source: [Telos RX](https://www.telosrx.com/blogs/glp1/zepbound-without-insurance-cost)